SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
10-K	Annual report which provides a comprehensive overview of the company for the past year	Mar 12, 2010	View HTML 0001047469-10-002142.pdf 0001047469-10-002142.rtf 0001047469-10-002142.xls
8-K	Report of unscheduled material events or corporate event	Mar 4, 2010	View HTML 0001157523-10-001399.pdf 0001157523-10-001399.rtf 0001157523-10-001399.xls
8-K	Report of unscheduled material events or corporate event	Feb 16, 2010	View HTML 0001104659-10-007163.pdf 0001104659-10-007163.rtf 0001104659-10-007163.xls
8-K	Report of unscheduled material events or corporate event	Jan 25, 2010	View HTML 0001104659-10-002734.pdf 0001104659-10-002734.rtf 0001104659-10-002734.xls
4	Statement of changes in beneficial ownership of securities	Jan 22, 2010	View HTML 0001179110-10-001344.pdf 0001179110-10-001344.rtf 0001179110-10-001344.xls
4	Statement of changes in beneficial ownership of securities	Jan 22, 2010	View HTML 0001179110-10-001345.pdf 0001179110-10-001345.rtf 0001179110-10-001345.xls
4	Statement of changes in beneficial ownership of securities	Jan 22, 2010	View HTML 0001179110-10-001346.pdf 0001179110-10-001346.rtf 0001179110-10-001346.xls
4	Statement of changes in beneficial ownership of securities	Jan 22, 2010	View HTML 0001179110-10-001347.pdf 0001179110-10-001347.rtf 0001179110-10-001347.xls
S-8 POS	Post-effective amendment to an S-8 filing	Jan 13, 2010	View HTML 0001104659-10-001541.pdf 0001104659-10-001541.rtf 0001104659-10-001541.xls
S-8 POS	Post-effective amendment to an S-8 filing	Jan 13, 2010	View HTML 0001104659-10-001542.pdf 0001104659-10-001542.rtf 0001104659-10-001542.xls

Data provided by Kaleidoscope.